Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2

Triage of HPV positive women in cervical cancer screening

(2016) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL VIROLOGY

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy

(2015) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening

(2015) Warner K. Huh et al.   OBSTETRICS AND GYNECOLOGY

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection

(2014) Julia C. Gage et al.   INTERNATIONAL JOURNAL OF CANCER

A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results

(2014) M. Schiffman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

(2014) J. C. Gage et al.   JNCI-Journal of the National Cancer Institute

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

(2013) L. Stewart Massad et al.   OBSTETRICS AND GYNECOLOGY

Comprehensive Control of Human Papillomavirus Infections and Related Diseases

(2013) F. Xavier Bosch et al.   VACCINE

Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: Results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany

(2012) Karl Ulrich Petry et al.   GYNECOLOGIC ONCOLOGY

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

(2009) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

(2008) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Heterogeneity in CIN3 diagnosis

(2008) Mark Schiffman et al.   LANCET ONCOLOGY